Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Pseudomyxoma peritonei of 92 Chinese patients: clinical characteristics, pathological classification and prognostic factors.

Guo AT, Li YM, Wei LX.

World J Gastroenterol. 2012 Jun 28;18(24):3081-8. doi: 10.3748/wjg.v18.i24.3081.

2.

[Prognostic value of clinical and pathological characteristics in 48 women with pseudomyxoma peritonei].

Lu YY, Guo AT, Liu AJ, Shi HY.

Zhonghua Fu Chan Ke Za Zhi. 2013 Aug;48(8):595-601. Chinese.

PMID:
24199925
4.

[Histologic classification and prognostic implication of pseudomyxoma peritonei].

Guo AT, Wei LX, Song X.

Zhonghua Bing Li Xue Za Zhi. 2007 Jul;36(7):474-9. Chinese.

PMID:
17845762
6.

Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review.

Bradley RF, Stewart JH 4th, Russell GB, Levine EA, Geisinger KR.

Am J Surg Pathol. 2006 May;30(5):551-9.

PMID:
16699309
7.

Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M.

Ann Surg Oncol. 2008 Feb;15(2):526-34. Epub 2007 Nov 28.

PMID:
18043976
8.

Significance of epithelial cell clusters in pseudomyxoma peritonei.

Badyal RK, Khairwa A, Rajwanshi A, Nijhawan R, Radhika S, Gupta N, Dey P.

Cytopathology. 2016 Dec;27(6):418-426. doi: 10.1111/cyt.12331. Epub 2016 Apr 28.

PMID:
27121698
9.

Gelatinous ascites: a cytohistologic study of pseudomyxoma peritonei in 67 patients.

Jackson SL, Fleming RA, Loggie BW, Geisinger KR.

Mod Pathol. 2001 Jul;14(7):664-71.

10.
11.

A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process.

Carr NJ, Cecil TD, Mohamed F, Sobin LH, Sugarbaker PH, González-Moreno S, Taflampas P, Chapman S, Moran BJ; Peritoneal Surface Oncology Group International.

Am J Surg Pathol. 2016 Jan;40(1):14-26. doi: 10.1097/PAS.0000000000000535.

PMID:
26492181
12.

Clinicopathological analysis of primary epithelial appendiceal neoplasms.

Gupta S, Parsa V, Adsay V, Heilbrun LK, Smith D, Shields AF, Weaver D, Philip PA, El-Rayes BF.

Med Oncol. 2010 Dec;27(4):1073-8. doi: 10.1007/s12032-009-9337-2. Epub 2009 Oct 23.

13.

Prognostic significance of single isolated cells with decreased E-cadherin expression in pseudomyxoma peritonei.

Koh YW, Jun SY, Kim KR.

Pathol Int. 2014 Apr;64(4):164-72. doi: 10.1111/pin.12157.

PMID:
24750186
14.
15.

COX-2 expression in pseudomyxoma peritonei.

Gatalica Z, Loggie B.

Cancer Lett. 2006 Nov 28;244(1):86-90. Epub 2006 Jan 19.

PMID:
16427185
16.

[Mucinous neoplasms of the vermiform appendix, Pseudomyxoma peritonei, and the new WHO classification].

Reu S, Neumann J, Kirchner T.

Pathologe. 2012 Feb;33(1):24-30. doi: 10.1007/s00292-011-1542-z. Review. German.

PMID:
22179200
17.
18.
19.

Histological origin of pseudomyxoma peritonei in Chinese women: clinicopathology and immunohistochemistry.

Guo AT, Song X, Wei LX, Zhao P.

World J Gastroenterol. 2011 Aug 14;17(30):3531-7. doi: 10.3748/wjg.v17.i30.3531.

20.

Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.

Vaira M, Cioppa T, DE Marco G, Bing C, D'Amico S, D'Alessandro M, Fiorentini G, DE Simone M.

In Vivo. 2009 Jul-Aug;23(4):639-44.

Supplemental Content

Support Center